Manas AI shortens early cancer drug discovery timelines
AI-generated summary Manas AI is reducing early-stage cancer drug discovery timeframes from nearly eight years to three or four months, according to co-founder and CEO Dr. Siddhartha Mukherjee. Dr. Siddhartha Mukherjee also discussed Immuneel Therapeutics, a cell therapy company he co-founded with Kiran Mazumdar-Shaw that develops customized blood cancer treatments.